Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multi-center Evaluation of the Safety and Effectiveness of the STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma

NCT05280366 is registered in ClinicalTrials.gov with New World Medical, Inc. as lead sponsor.

NCT NCT05280366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05280366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multi-center Evaluation of the Safety and Effectiveness of the STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma
Lead sponsor
New World Medical, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
February 9, 2022
Completion date
June 30, 2026
Enrollment
150 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

open angle glaucoma